Trevi Therapeutics
Stock Forecast, Prediction & Price Target

Trevi Therapeutics Financial Estimates

Trevi Therapeutics Revenue Estimates

Trevi Therapeutics EBITDA Estimates

Trevi Therapeutics Earnings per Share Estimates

Passed Analyst forecast
Metric 12/31/2021 12/31/2022 12/31/2023 12/31/2025 12/31/2026 12/31/2027 12/31/2028
Revenue
 
% change YoY
$0
 
N/A
$0
 
0%
$0
 
0%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $1.18M
Low: $1.18M
High: $1.18M
avg. 0%
Avg: $12.23M
Low: $12.23M
High: $12.23M
avg. 936.45%
Avg: $113.25M
Low: $113.25M
High: $113.25M
avg. 826.03%
Net Income
 
% change YoY
$-33.94M
 
N/A
$-29.15M
 
14.10%
$-29.06M
 
0.29%
Avg: $-53.5M
Low: $-61.40M
High: $-37.63M
avg. -84.07%
Avg: $-79.1M
Low: $-87.14M
High: $-49.51M
avg. -47.85%
Avg: $-70.90M
Low: $-70.90M
High: $-70.90M
avg. 10.35%
Avg: $-12.28M
Low: $-12.28M
High: $-12.28M
avg. 82.68%
EBITDA
 
% change YoY
$-32.79M
 
N/A
$-29.90M
 
8.79%
$-33.8M
 
-13.01%
Avg: $0
Low: $0
High: $0
avg. 100%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%
EPS
 
% change YoY
-$1.49
 
N/A
-$0.45
 
69.79%
-$0.29
 
35.55%
Avg: -$0.46
Low: -$0.62
High: -$0.38
avg. -58.62%
Avg: -$0.68
Low: -$0.88
High: -$0.5
avg. -48.54%
Avg: -$0.72
Low: -$0.72
High: -$0.72
avg. -4.78%
Avg: -$0.12
Low: -$0.12
High: -$0.12
avg. 82.68%
Operating Expenses
 
% change YoY
$32.47M
 
N/A
$29.90M
 
-7.91%
$33.92M
 
13.42%
Avg: $0
Low: $0
High: $0
avg. -100%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%

FAQ

What is Trevi Therapeutics stock earnings growth forecast?

Wall Street analysts estimate the annual average earnings growth rate of -9.72% in 2025-2028.

We have gathered data from 4 analysts. Their low estimate is -61.40M, average is -53.5M and high is -37.63M.

What is Trevi Therapeutics stock revenue growth forecast?

Wall Street analysts forecast annual average revenue growth of 440.62% in 2025-2028.

We have gathered data from 5 analysts. Their low revenue estimate is N/A, average is N/A and high is N/A.

What is Trevi Therapeutics stock earnings per share growth forecast?

Wall Street analysts forecast annual average earnings growth of -7.31% in 2025-2028.

We have gathered data from 4 analysts. Their low earnings per share estimate is -$0.62, average is -$0.46 and high is $-0.38.

What is the best performing analyst?

In the last twelve months analysts have been covering Trevi Therapeutics stock. The most successful analyst is Oren Livnat.